Cite

HARVARD Citation

    Rozenbaum, M. et al. (n.d.). Baseline characteristics of patients with transthyretin amyloid cardiomyopathy enrolled in a tafamidis expanded access programme. European heart journal. p. . [Online]. 
  
Back to record